pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Radiology startups say owning clinics speeds AI tool development as insurers resist new RPM rules

Sep 24, 2026·read at STAT ↗Neutral

Radiology startups argue that owning their own imaging practices gives them direct access to patient scans and workflow data, which they say accelerates the creation and testing of artificial‑intelligence tools.

They describe this model as an "AI‑native" radiology practice, allowing rapid iteration of algorithms and real‑world validation without relying on external partners.

At the same time, insurers are pushing back against proposed changes to remote patient monitoring reimbursement, warning that the new rules could limit the financial viability of such AI‑driven services.

The clash underscores the broader challenge of aligning innovative AI solutions with existing reimbursement structures and regulatory expectations in the radiology field.

source

This writeup was produced by pharmadog from original reporting by STAT. The original article may no longer be reachable at its published URL.

Original headline: “STAT+: The rise of the AI-native radiology practice”

read at STAT ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 39m agoSenate Finance committee backs Chris Klomp, advancing him to full Senate voteSTAT
  • 2h agoSTAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates saySTAT
  • 3h agoSTAT+: Kyverna’s cell therapy shows lasting autoimmune benefitSTAT
  • 3h agoSTAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and moreSTAT
  • 5h agoOne of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991STAT